ONO PHARMACEUTICAL CO., LTD.
4528 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大阪市中央区道修町二丁目１番５号
- Website:
- https://www.ono-pharma.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ONO PHARMACEUTICAL CO., LTD., founded in 1717, has been dedicated to enhancing global health for over 300 years. With a commitment to addressing unmet medical needs, ONO focuses on innovative drug discovery aimed at combating diseases and alleviating pain. The company strives to deliver new therapeutic solutions to patients around the world, reflecting its core mission of fulfilling patients' wishes. In addition to advancing healthcare, ONO is committed to achieving a sustainable society through long-term environmental targets and improving access to healthcare. The company actively engages in social contribution activities, underlining its dedication to not only pharmaceutical innovation but also to broader societal well-being.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-01 09:06 |
Regulatory News Service
確認書
|
Japanese | 9.2 KB | |
| 2025-07-01 09:00 |
Regulatory News Service
訂正有価証券報告書－第77期(2024/04/01－2025/03/31)
|
Japanese | 1.3 MB | |
| 2025-06-20 02:00 |
Inside Information Statement
臨時報告書
|
Japanese | 25.3 KB | |
| 2025-06-19 09:06 |
Inside Information Statement
臨時報告書
|
Japanese | 39.9 KB | |
| 2025-06-19 09:05 |
Inside Information Statement
臨時報告書
|
Japanese | 41.7 KB | |
| 2025-06-19 09:02 |
Internal Control over Financial Reporting
内部統制報告書－第77期(2024/04/01－2025/03/31)
|
Japanese | 26.0 KB | |
| 2025-06-19 09:01 |
Regulatory News Service
確認書
|
Japanese | 9.2 KB | |
| 2025-06-19 09:00 |
Annual Report
有価証券報告書－第77期(2024/04/01－2025/03/31)
|
Japanese | 2.5 MB | |
| 2024-11-06 01:00 |
Interim Report
半期報告書－第77期(2024/04/01－2025/03/31)
|
Japanese | 334.0 KB | |
| 2024-11-06 01:00 |
Regulatory News Service
確認書
|
Japanese | 9.1 KB | |
| 2024-06-21 02:05 |
Inside Information Statement
臨時報告書
|
Japanese | 27.2 KB | |
| 2024-06-21 02:04 |
Internal Control over Financial Reporting
内部統制報告書－第76期(2023/04/01－2024/03/31)
|
Japanese | 24.4 KB | |
| 2024-06-21 02:03 |
Regulatory News Service
確認書
|
Japanese | 9.2 KB | |
| 2024-06-21 02:02 |
Annual Report
有価証券報告書－第76期(2023/04/01－2024/03/31)
|
Japanese | 2.3 MB | |
| 2024-06-20 09:00 |
Inside Information Statement
臨時報告書
|
Japanese | 43.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |